Modified variant Bowman Birk Protease Inhibitors
    2.
    发明授权
    Modified variant Bowman Birk Protease Inhibitors 有权
    改良型Bowman Birk蛋白酶抑制剂

    公开(公告)号:US08394941B2

    公开(公告)日:2013-03-12

    申请号:US13082979

    申请日:2011-04-08

    IPC分类号: C12N15/00

    CPC分类号: C07K14/811 A61K8/64 A61Q7/02

    摘要: The present invention relates to modified variant Bowman Birk Protease Inhibitor proteins (BBPIs) that comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses polynucleotide constructs and expression vectors containing polynucleotide sequences that encode the modified variant BBPIs, the transformed host cells that express and produce the modified variant BBPIs, the modified variant BBPI proteins, the compositions comprising the modified variant BBPIs, and the methods for making and using the modified variant BBPIs in personal care.

    摘要翻译: 本发明涉及包含结合靶蛋白的肽的修饰变体Bowman Birk蛋白酶抑制剂蛋白(BBPI),并且被进一步修饰以具有比未修饰的BBPI更大的蛋白酶抑制活性和/或以更高的产量产生。 本发明包括多核苷酸构建体和含有编码修饰变体BBPI的多核苷酸序列的表达载体,表达和产生修饰变体BBPI的转化宿主细胞,修饰变体BBPI蛋白,包含修饰变体BBPI的组合物和制备方法 并在个人护理中使用修改后的变体BBPI。

    Modified Variant Bowman Birk Protease Inhibitors
    4.
    发明申请
    Modified Variant Bowman Birk Protease Inhibitors 有权
    改良变体Bowman Birk蛋白酶抑制剂

    公开(公告)号:US20100221780A1

    公开(公告)日:2010-09-02

    申请号:US12779793

    申请日:2010-05-13

    IPC分类号: C12P21/00

    CPC分类号: C07K14/811 A61K8/64 A61Q7/02

    摘要: The present invention relates to modified variant Bowman Birk Protease Inhibitor proteins (BBPIs) that comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses polynucleotide constructs and expression vectors containing polynucleotide sequences that encode the modified variant BBPIs, the transformed host cells that express and produce the modified variant BBPIs, the modified variant BBPI proteins, the compositions comprising the modified variant BBPIs, and the methods for making and using the modified variant BBPIs in personal care.

    摘要翻译: 本发明涉及包含结合靶蛋白的肽的修饰变体Bowman Birk蛋白酶抑制剂蛋白(BBPI),并且被进一步修饰以具有比未修饰的BBPI更大的蛋白酶抑制活性和/或以更高的产量产生。 本发明包括多核苷酸构建体和含有编码修饰变体BBPI的多核苷酸序列的表达载体,表达和产生修饰变体BBPI的转化宿主细胞,修饰变体BBPI蛋白,包含修饰变体BBPI的组合物和制备方法 并在个人护理中使用修改后的变体BBPI。

    Peptides and supported peptides for treating skin diseases
    5.
    发明授权
    Peptides and supported peptides for treating skin diseases 有权
    用于治疗皮肤疾病的肽和支持的肽

    公开(公告)号:US07524816B2

    公开(公告)日:2009-04-28

    申请号:US10984270

    申请日:2004-11-08

    IPC分类号: A61K38/16

    摘要: The present invention provides peptides and supported peptides for treating proliferative diseases. In particularly preferred embodiments, the present invention provides peptides and supported peptides for treating diseases of the skin, such as rosacea. In some particularly preferred embodiments, the supported peptides of the present invention are anti-VEGF peptides. In alternative particularly preferred embodiments, the anti-VEGF peptides are expressed on a scaffold protein. In some most preferred embodiments, the scaffold proteins is BBI.

    摘要翻译: 本发明提供用于治疗增殖性疾病的肽和负载肽。 在特别优选的实施方案中,本发明提供用于治疗皮肤疾病的肽和负载肽,例如红斑痤疮。 在一些特别优选的实施方案中,本发明的负载型肽是抗VEGF肽。 在替代的特别优选的实施方案中,抗VEGF肽在支架蛋白上表达。 在一些最优选的实施方案中,支架蛋白是BBI。

    PEPTIDES AND SUPPORTED PEPTIDES FOR TREATING SKIN DISEASES
    8.
    发明申请
    PEPTIDES AND SUPPORTED PEPTIDES FOR TREATING SKIN DISEASES 审中-公开
    用于治疗皮肤疾病的肽和支持肽

    公开(公告)号:US20130065829A1

    公开(公告)日:2013-03-14

    申请号:US13609116

    申请日:2012-09-10

    摘要: The present invention provides peptides and supported peptides for treating proliferative diseases. In particularly preferred embodiments, the present invention provides peptides and supported peptides for treating diseases of the skin, such as rosacea. In some particularly preferred embodiments, the supported peptides of the present invention are anti-VEGF peptides. In alternative particularly preferred embodiments, the anti-VEGF peptides are expressed on a scaffold protein. In some most preferred embodiments, the scaffold protein is BBI.

    摘要翻译: 本发明提供用于治疗增殖性疾病的肽和负载肽。 在特别优选的实施方案中,本发明提供用于治疗皮肤疾病的肽和负载肽,例如红斑痤疮。 在一些特别优选的实施方案中,本发明的负载型肽是抗VEGF肽。 在替代的特别优选的实施方案中,抗VEGF肽在支架蛋白上表达。 在一些最优选的实施方案中,支架蛋白是BBI。

    Modified variant bowman birk protease inhibitors
    9.
    发明授权
    Modified variant bowman birk protease inhibitors 有权
    改良型bowman birk蛋白酶抑制剂

    公开(公告)号:US07803902B2

    公开(公告)日:2010-09-28

    申请号:US12252062

    申请日:2008-10-15

    IPC分类号: C07K14/00

    CPC分类号: C07K14/811 A61K8/64 A61Q7/02

    摘要: The present invention relates to modified variant Bowman Birk Protease Inhibitor proteins (BBPIs) that comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses polynucleotide constructs and expression vectors containing polynucleotide sequences that encode the modified variant BBPIs, the transformed host cells that express and produce the modified variant BBPIs, the modified variant BBPI proteins, the compositions comprising the modified variant BBPIs, and the methods for making and using the modified variant BBPIs in personal care.

    摘要翻译: 本发明涉及包含结合靶蛋白的肽的修饰变体Bowman Birk蛋白酶抑制剂蛋白(BBPI),并且被进一步修饰以具有比未修饰的BBPI更大的蛋白酶抑制活性和/或以更高的产量产生。 本发明包括多核苷酸构建体和含有编码修饰变体BBPI的多核苷酸序列的表达载体,表达和产生修饰变体BBPI的转化宿主细胞,修饰变体BBPI蛋白,包含修饰变体BBPI的组合物和制备方法 并在个人护理中使用修改后的变体BBPI。